Skin patch trial aims to slow devastating kidney disease
NCT ID NCT06291116
Summary
This study is testing whether a low-dose dopamine patch (rotigotine) is safe and tolerable for people with inherited polycystic kidney disease (ADPKD) over two years. It will involve 120 adults with ADPKD to see if the patch can help slow the disease's progression and protect kidney and heart health. The main goal is to check for side effects, while also gathering early information on whether the treatment helps preserve kidney function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY DISEASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.